Disclosed are methods for determining whether a melanocyte-containing sample (such as a nevus or other pigmented lesion) is benign or a primary melanoma. These methods can include detecting (at the molecular level, e.g., mRNA, miRNA, or protein) the expression of at least two disclosed genes in a biological sample obtained from a subject. Also provided are arrays and kits that can be used with the methods.
申请公布号
CA2875710(A1)
申请公布日期
2013.12.27
申请号
CA20132875710
申请日期
2013.06.24
申请人
JOHN WAYNE CANCER INSTITUTE;HTG MOLECULAR DIAGNOSTICS, INC.